(₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
---|---|---|---|---|---|
Total Income | 1468.15 | 1901.61 | 1254.73 | -22.8% | 17.0% |
Total Expenses | 1132.42 | 1519.11 | 954.05 | -25.5% | 18.7% |
Profit Before Tax | 335.73 | 308.87 | 300.68 | 8.7% | 11.7% |
Tax | 84.19 | 70.07 | 49.76 | 20.2% | 69.2% |
Profit After Tax | 251.54 | 238.80 | 250.92 | 5.3% | 0.2% |
Earnings Per Share | 2.60 | 2.40 | 2.60 | 8.3% | 0.0% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Max Healthcare Institute Ltd is a prominent player in the healthcare industry, primarily focusing on providing healthcare services. The company operates a chain of hospitals and healthcare facilities across India, catering to a wide range of medical needs. As of the last available data, the company has been actively expanding its operations to enhance its service offerings and reach. While specific recent developments beyond October 2023 are not available, Max Healthcare Institute has been known for its emphasis on technological integration in healthcare services and strategic partnerships to improve healthcare delivery. The company is recognized for its comprehensive medical services, including advanced diagnostics, surgery, and patient care.
For the fourth quarter of FY25, Max Healthcare Institute Ltd reported total income of ₹1468.15 crores, a decrease of 22.8% compared to the previous quarter (Q3FY25) where the total income was ₹1901.61 crores. However, when compared to the fourth quarter of the previous fiscal year (Q4FY24), there is a 17.0% increase from ₹1254.73 crores. This year-over-year growth indicates an upward trend in the company's revenue on an annual basis, despite the quarter-over-quarter decline. This fluctuation in revenue suggests variability in income, which is a common occurrence in the healthcare sector due to seasonal and operational dynamics.
Profitability for Max Healthcare Institute Ltd showed an improvement in Q4FY25, with the Profit Before Tax (PBT) rising to ₹335.73 crores, marking an 8.7% increase from the previous quarter's profit of ₹308.87 crores. When compared to the same quarter last year, PBT rose by 11.7% from ₹300.68 crores, reflecting consistent growth in profitability. The Profit After Tax (PAT) for Q4FY25 stood at ₹251.54 crores, which is a 5.3% increase from the previous quarter's ₹238.80 crores, and a marginal year-over-year increase of 0.2% from ₹250.92 crores in Q4FY24. The tax expense for Q4FY25 was ₹84.19 crores, showing a significant increase of 20.2% from the previous quarter and 69.2% year-over-year, which impacts the net profit figures.
The total expenses for Q4FY25 amounted to ₹1132.42 crores, reflecting a decrease of 25.5% from the previous quarter's expenses of ₹1519.11 crores. Compared to Q4FY24, expenses increased by 18.7% from ₹954.05 crores, indicating a year-over-year rise in operational costs. Earnings Per Share (EPS) remained stable year-over-year at ₹2.60, although there was an 8.3% increase from the previous quarter's EPS of ₹2.40. This stability in EPS year-over-year, despite fluctuations in income and expenses, suggests a controlled management of share earnings. Further detailed financial ratios such as P/E ratio, debt-to-equity ratio, and current ratio require additional data beyond what is provided, as they depend on market values and balance sheet specifics not included in the financial data.